Table 2 Five-year survival (%) and hazard ratios (HR) by level treatment at PTC and diagnostic group

Leukaemia

All

81

(78, 84)

1

-

1

-

Some

57

(44, 68)

2.34

(1.54, 3.56)

1.61

(0.97, 2.67)

None

56

(41, 69)

2.66

(1.68, 4.20)

1.73

(0.98, 3.04)

Lymphoma

All

89

(85, 92)

1

-

1

-

Some

84

(74, 90)

1.45

(0.84, 2.51)

1.51

(0.78, 2.92)

None

89

(82, 93)

0.98

(0.56, 1.70)

1.12

(0.54, 2.35)

CNS tumours

All

71

(67, 75)

1

-

1

-

Some

76

(52, 89)

0.6

(0.25, 1.48)

0.48

(0.19, 1.20)

None

72

(55, 84)

0.98

(0.54, 1.75)

0.66

(0.34, 1.29)

Germ cell tumours

All

91

(85, 95)

1

-

1

-

Some

94

(88, 97)

0.76

(0.34, 1.70)

1.24

(0.42, 3.65)

None

95

(88, 98)

0.62

(0.22, 1.17)

1.83

(0.50, 6.76)

Soft tissue sarcomas

All

54

(45, 63)

1

-

1

-

Some & None

75

(59, 85)

0.44

(0.23, 0.83)

0.48

(0.23, 0.99)

Bone tumours

All

56

(47, 64)

1

-

1

-

Some & None

60

(36, 78)

0.98

(0.49, 1.97)

0.91

(0.43, 1.88)